<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Radiation-induced malignant fibrous histiocytoma of the occipital: a case report.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Radiation-induced malignant fibrous histiocytoma of the occipital: a case report." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef47/3999727/8842a3b15041/1477-7819-12-98-1.jpg"/> </div> <div class="text-side"> <h1>Radiation-induced malignant fibrous histiocytoma of the occipital: a case report.</h1> <p>Pathological characteristics of the patient. A) High-power photomicrograph of the lesion, eight years previously, which was diagnosed as medulloblastoma (H &amp; E, 200×). B) High-power photomicrograph showing proliferation of pleomorphic spindle-shaped cells having large irregular nuclei with hyperchromasia (H &amp; E, 200×). C-I) Photomicrograph of tumor with immunohistochemical stain (200×). C) Vimentin demonstrating a strongly positive reaction in the tumor cells. D) CD68 demonstrating a strongly positive reaction in the tumor cells. E) Fibronectin (FN) demonstrating a strongly positive reaction in the tumor cells. F) Desmin showing negative reaction in the tumor cells. G) S-100 showing negative reaction in the tumor cells. H) Cytokeratins showing negative reaction in the tumor cells. I) Ki-67 (MIB-1) demonstrating positive reaction in the tumor cells. The MIB-1 labeling index is 10%.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24742094/" target="_blank">24742094</a></p><p>Type: Benign, Category: Fibrohistiocytic</p>
</div> </div></div></body></html>